The purpose of this study was to determine the effect of dendritic cell (DC) transfers on the incidence of diabetes in female nonobese diabetic (NOD) mice. Groups of 4-wk-old NOD female mice were given a single foot pad of DCs (70-90% purity) isolated from the draining lymph nodes (LN) of the pancreas (PLN), the cervical LNs, or the axillary/inguinal LNs. In addition, other groups of NOD mice received purified spleen DCs, purified PLN T cells (the major contaminating population in DC preparations), or the injection vehicle PBS. All groups were monitored for diabetes for one year.
Introduction
The nonobese diabetic (NOD)' mouse is a well established model oftype 1 diabetes (1) (2) (3) (4) . NOD mice universally develop insulitis but not all animals develop diabetes (5) . Approximately 25% of NOD/Ym female mice and 70% of male mice do not develop diabetes (UCLA colony data). A reduction in the incidence of diabetes in NOD mice has been accomplished by a number of nonspecific manipulations including injection 1 . Abbreviations used in this paper: A/I, axillary/inguinal; DC, dendritic cell; LN, lymph nodes; NOD, nonobese diabetic; PLN, pancreatic LN; SMG, submandibular gland; SMLR, syngenetic mixed lymphocyte response.
of CFA, viruses, and the cytokines IL-1, IL-2, and tumor necrosis factor (TNF) (6) (7) (8) (9) . Investigators have suggested that the NOD mouse contains cells that function to inhibit the autoimmune response which may be enhanced by these maneuvers (6, 8, 10) . For example, natural suppressor cells can be augmented in NOD mice by the administration of CFA (6) . Other studies have suggested that protective cells are CD4-positive T cells that are found in unmanipulated NOD mice, to varying degrees at different ages ( 10) .
The "honeymoon period," an apparent spontaneous remission oftype 1 diabetes seen in some new onset patients may represent a down modulation of the autoimmune response for a briefperiod oftime. Peripheral blood leukocyte analysis from prediabetic patients suggests that there are increased numbers of cells with the suppressor/inducer phenotype before diabetes onset and the number of these cells diminishes at the time of diabetes onset ( 11 ) . Combined, these animal and human studies suggest that the autoimmune response to the beta cell can be modulated, perhaps through regulatory cells.
Regulatory or effector T cells responses may be induced by stimulation with antigen-presenting cells. The dendritic cell (DC), a unique antigen-presenting cell, may play an important role in the regulation of the autoimmune response. Various investigators have demonstrated that DCs are able to transfer experimental autoimmune diseases such as thyroiditis and encephalomyelitis with great efficiency (12) (13) (14) . Conversely, DCs also have the potential to control the autoimmune response by a variety of mechanisms. DCs are the chief stimulators of the syngeneic mixed lymphocyte response (SMLR) (15) . The SMLR, which is depressed in NOD mice ( 16) , may be important in the generation of suppressor/inducer cells ( 17) . Furthermore DCs pulsed with a high concentration ofan antigen can inhibit the immune response to that antigen ( 18) . In contrast pulsing with low antigen concentrations stimulates the immune response ( 18) . DCs also participate in the thymic selection of the T cell repertoire ( 19) . In addition, these antigen-presenting cells may play a role in the shaping ofperipheral tolerance (20) . Thus DCs have the potential to modify the autoimmune response.
Little is known about the function ofDCs in NOD mice. As discussed DCs could function to either augment or reduce the autoimmune response of NOD mice. We chose to investigate the function of DCs in the NOD mouse in transfer experiments. We were particularly interested in ascertaining the function of pancreatic lymph node (PLN) DCs for the following reasons. First, DCs are an early component of the islet infiltrate in the animal models of type 1 diabetes (21, 22). In addition, DCs have been shown to take up antigen in tissues and travel via the afferent lymphatics to the draining LNs where they stimulate immune responses (23, 24 Histology. NOD pancreata were removed at sacrifice. The pancreata were fixed in 10% buffered formalin, processed, and paraffin sections examined. Five interrupted serial sections cut 150 ,m apart were stained for insulin by indirect immunohistochemistry, and then counterstained with hematoxylin. The five sections were scored blindly by an independent observer. The data obtained were analyzed by a second blinded observer. The scoring system employed used a 1 to 10 point scale illustrated in Fig. 1 . In addition the number ofislets in each section was counted and the total for five sections was averaged.
Diabetes transfer protocol. The protocol used for the transfer of diabetes was that described by Wicker et al. (4) . Briefly, 8-ll-wk-old NOD female mice were irradiated (850 rads) and then given 2.0 x 107 spleen cells by tail vein injection from an acutely diabetic NOD female (diabetes duration < 30 d). The mice were then observed daily for the development of diabetes by urine glucose monitoring. Mice that were glycosuric were then tested for blood glucose by chemstrip. Diabetic mice demonstrated glucose values > 300 mg/dl.
Inhibition ofdiabetes transfer. A modified 2-d transfer protocol was used to test the ability of cell populations to inhibit the transfer of diabetes. This protocol was similar to that described by Boitard et al. ( 10) . Briefly, mice were irradiated as before and on day one given intravenous injections ofeither 2.0 X I07 LN cells from 1-yr-old nondiabetic NOD mice that had received PLN DC transfers. The LN cells were pooled from the cervical, axillary, inguinal, PLN, and peri-aortic LNs. Other recipients received the same number of LN cells from donors that were age-and sex-matched NOD mice that did not receive PLN DC transfers. On the second day both groups received injections of 2.0 x I07 spleen cells from acutely diabetic NOD mice. In addition in each of the 2-d transfers an internal control group received the same dose of diabetic spleen cells alone.
Results
DC migration after footpad injection. The migration of DCs was assessed after labeling these cells with a nuclear vital fluorescein dye. These labeled cells, purified from the PLNs of 1 2-wkold NOD female mice, were injected into the footpad of 4-wkold NOD female mice. The labeled DCs were found only in the popliteal LN when examined on day 3 and 5 after injection. Fluorescent Table I ). The level ofproliferative activity ofpopliteal LN cells that had been exposed to A/I LN DC or PBS were essentially equal.
These data suggest that PLN DCs are capable of producing cell proliferation in the popliteal LN to a greater degree than DCs isolated from LNs that are not associated with the lymphatic drainage of the pancreas.
DC transfers. 4-wk-old NOD female mice were given bilateral footpad injections of pooled DCs (8-12 NOD mice) isolated from the spleens and various LNs ofNOD mice that were 8-20 wk of age. DCs populations used in transfer experiments were consistently of 70-90% purity. The remaining cells were composed of T lymphocytes (10-20%), B lymphocytes (< 5%), and macrophages (5-10%) (data not shown). Recipient mice received various doses of DC (1 x 104 to 2 x 105/ mouse (see Fig. 2) . The mice were then observed for the development of diabetes for one year. There was a 100% survival of NOD mice in experimental and control groups that remained nondiabetic during the observation period. Once animals became diabetic, survival was limited to a few weeks with insulin therapy. During the period ofexperimentation the incidence of diabetes in 1-yr-old NOD female colony mice was -75-78%. This percentage has remained consistent over several years. The results of these experiments are displayed in Fig. 2 . NOD mice that received injections of PBS developed diabetes in 7 of 10 recipients. NOD mice that had received DCs from LNs not associated with the pancreas, i.e., the A/I LN, developed diabetes at a rate identical to that of the colony (78%).
This was also true for the cervical LN DC population. Cervical LNs are the draining LN of the submandibular gland (SMG). The SMG ofNOD mouse is also involved in an inflammatory process (sialitis). The sialitis process occurs concurrently the insulitis process of the pancreas (21 ). Cervical LN DCs were given to recipients to test the hypothesis that DC from a draining LN of an inflamed gland other than the pancreas were equally as effective in preventing diabetes. Cervical DCs however were found to provide no protection from diabetes (8:10; 80% diabetes).
Nylon wool-purified PLN T cells were also given to recipients in a dose that was equivalent to the number of T cells found in PLN DC preparations ( and another group received the injection vehicle PBS.
The mice were checked weekly for a period of one year for the onset of glycosuria by tes-tape. If mice were found to be glycosuric diabetes was confirmed by chemstrip. The incidence of diabetes in each group is plotted in this figure as a function of time (weeks). Pancreatic histology ofNOD mice. The effect of PLN DC transfers on the insulitis process of NOD mouse recipients was assessed by histologic examination of the pancreas. In a pilot study four female NOD mice that received PLN DCs at 4 wk of age and four female NOD mice that received PBS injections at the same age were killed at 8 wk of age and their pancreata examined. The NOD mice that received PLN DCs did not have any evidence oflymphocytic infiltration in the islets examined, whereas the PBS injected mice all had evidence of insulitis at this age (data not shown).
In the follow up study the pancreata ofNOD mice that had received either PLN DCs or A/I DCs at 4 wk of age, and then became diabetic, were evaluated histologically within 4-8 wk of the onset of their disease (see Table II ). In addition, the pancreata of untreated female NOD colony mice were also examined within 4-6 wk of the onset of their diabetes. The islets of all of the diabetic NOD groups (including those that had received PLN DCs) were infiltrated with a large number of lymphocytes and were small in size in comparison to those of the nondiabetic group (data not shown). The average infiltrate score for these diabetic animals were similar (range; 8.1-9.2). Very few islets in the pancreas ofthe diabetic groups were positive for insulin by immunohistochemistry. The pancreata of NOD mice that had received PLN DCs demonstrated a histologic score similar to that of the other diabetic mice examined. The PLN DC recipients however demonstrated more islets per section (average 15.3 per five sections). This difference, however, did not reach statistical significance.
The pancreata ofNOD that had received PLN DCs at 4 wk of age, but failed to develop clinical diabetes, were examined when the animals reached 1 yr ofage or greater. In addition, the pancreata of age-sex matched colony NOD mice that failed to develop diabetes were also examined. The histologic appearance of the islets ofboth of the nondiabetic groups were markedly different from their diabetic counterparts. As seen in Table II, the number of surviving islets was much greater and the infiltration scores were far lower than those ofdiabetic animals. The pancreata of diabetic female NOD mice that had received no treatment (spontaneous colony diabetes), and NOD mice that developed diabetes after receiving either NOD PLN or A/I DCs at 4 wk of age were examined histologically in paraffin sections stained with hematoxylin, and for insulin by immunocytochemistry within 4-8 wk of disease onset. In addition the pancreata of nondiabetic 1-yr-old NOD PLN DC recipients, and nondiabetic age-sex matched colony mice, were examined in a similar fashion. The pancreata of all mice were scored blindly using a 10-point scale (see Fig. 1 ). Untreated diabetic NOD mice had few islets that were negative for insulin. Diabetic NOD mice that had received PLN DCs had greater numbers of islets/five sections ( 15.3) than did the other two diabetic NOD groups. The colony nondiabetic NOD mice had markedly lower infiltrate scores and many large insulin-positive islets. NOD mice that received PLN DCs had significantly lower infiltration scores than those of colony nondiabetic animals (* P < 0.05). Results are expressed as an average±SD. Analysis of variance was performed using the post hoc t test.
The NOD mice that received PLN DCs demonstrated significantly lower infiltration scores than those of the nondiabetic NOD mice that did not receive PLN DC transfers (P < 0.05; t test). The islets of NOD mice that received PLN DC transfers were often completely free of infiltration. If lymphocytic accumulation did occur, it remained outside of the islet in the periductal region. Inhibition ofdiabetes transfer. The possibility that cell-mediated suppression of insulitis and diabetes is enhanced in NOD mice that received PLN DCs was assessed in a modified adoptive transfer setting. 100% of NOD female recipients that were irradiated and then injected with diabetic spleen cells 48 h later developed diabetes within 22 d oftransfer (see Fig. 3 ). To test for the inhibition ofdiabetes transfer LN cells (pooled from the cervical, A/I, PLN, peri-aortic LN, and popliteal LN) from NOD mice were given to irradiated NOD female recipients on day one, followed by diabetic spleen cells on day two. LN cells from 1-yr-old nondiabetic female NOD mice that did not receive DC transfers initially inhibited the transfer of diabetes in some animals (5:8 [63%] animals became diabetic at 22 d). This protection, however, was short lived in that 8:8 recipients became diabetic within 36 d of transfer (see Fig. 3 ).
When irradiated NOD mice were injected with pooled LN cells from nondiabetic female NOD mice that received PLN DC on day one the transfer ofdiabetes was markedly inhibited. 31% (5:16) received PLN DC transfer were protected to a significantly greater degree that animals from the other two transfer groups (P = 0.0015). These experiments suggests that NOD mice that received PLN DC transfers contain cellular elements that inhibit the transfer of diabetes to a greater degree than LN cells from agematched nondiabetic control NOD mice. There was, however, an initial delay in the transfer of diabetes in some animals that received LN cells from 1-yr-old unmanipulated NOD mice given on day one. 1-yr-old nondiabetic mice have a low probability ofdeveloping spontaneous diabetes and may contain regulatory elements that inhibit the development of the disease in these animals. It may be that PLN DC transfers enhance similar regulatory elements in transferred animals.
Discussion
In these studies we demonstrate that PLN DC transfers markedly perturb the autoimmune response of prediabetic NOD mice and prevent diabetes in the majority ofrecipient animals. PLN DCs, when compared to DCs isolated from other LN groups, were unique in their ability to protect recipients from diabetes. Histologic examination ofthe islets of 1-yr-old nondiabetic NOD mice that received PLN DCs demonstrated a low degree of lymphocytic infiltration suggesting that a single transfer of PLN DCs was able to inhibit, but not completely ablate, the autoimmune process. Furthermore, LN cells from NOD mice that received PLN DC transfers markedly inhibited the adoptive transfer ofdiabetes by diabetic spleen cells demonstrating that these recipients contained potent regulatory cells. These studies suggest that PLN DCs may play an important role in the regulation of autoimmunity.
Ofparticular interest was the finding that isolated PLN DCs in comparison to other populations of NOD LN DCs were highly effective at modulating the autoimmune response. There are a number of potential explanations for the unique protective effect provided by PLN DC transfers. First, cytokines such as IL-1 orgranulocyte macrophage-colony-stimulating factor are known to augment DC function. It could be envisaged that PLN DCs are "activated" upon exposure to these cytokines produced in the inflamed islet (27, 28 Recently Eynon and Parker demonstrated in vivo that small resting B cells induce antigen specific T cell tolerance when soluble antigens (Fab fragments of rabbit-anti-mouse IgD) are targeted to these cells (35) . B cells contained in the PLN DC populations appear to be of the small, resting type (data not shown). Tolerance in their system, however, is not permanent and lasts only a few weeks. These authors suggest that the mechanism of antigen-specific tolerance induction is through deletion or inactivation ofT cells in the periphery by B cells presenting the soluble antigen. It may be that resting B cells in the PLN DC preparation induce anergy or delete autoreactive T cells in recipient NOD mice. Our data, however, suggest that the mechanisms of self tolerance generated by PLN DC transfers is different from that suggested for B cells by Enyon and Parker (35 Further evidence for the modulatory effect of B cells and macrophages comes from the work of Ben-nun and Yossefi in the experimental autoimmune encephalomyelitis (EAE) model (36) . These investigators demonstrated that pretreatment of recipients with intraperitoneal injections of gamma interferon-treated macrophages and B cells pulsed with myelin basic protein (MBP) before myelin basic protein and adjuvant immunization, blocked the development of EAE. They suggested that the mechanism of protection provided by MBPpulsed macrophages and B cells is by the diversion ofautoreactive cells away from the target organ, the central nervous system.
Our experiments differ in several important ways from those of Ben-nun and Yossefi (36) . First, B cells and macrophages were treated with gamma interferon, and the numbers of B cells and macrophages used in these experiments was 100-fold greater than the number of t4ese cells contaminating our DC preparations. Our results suggest that the mechanism of protection of PLN DC transfers is not mediated by the diversion of autoreactive cells away from the target organ as suggested by Ben-nun and Yoseffi for macrophages and B cells, but instead is mediated by potent regulatory cells that effectively inhibit the transfer of diabetes. Furthermore, we found no evidence to support the diversion of autoreactive lymphocytes as there was no accumulation of lymphocytes in the footpads of recipients nor was there enlargement of the popliteal LNs of NOD mice that received PLN DC transfers.
However, because of the potential contribution of PLN B cells and macrophages to the potent protective effect of PLN DC transfers it will be important to evaluate the contribution of each of these cell types to this phenomena. We are currently evaluating the effect of the transfer of each of these PLN antigen-presenting cells on the incidence of diabetes in the NOD mouse. It may be that therapeutic strategies using B cells, macrophages, or DCs pulsed with antigens relevant to the autoimmune response will provide viable approaches to the modulation or prevention of clinical autoimmune disease.
Viruses such as murine hepatitis virus are known to modify the incidence of diabetes in NOD colonies (37) . The low incidence of diabetes in the PLN DC group could be due to the presence of viruses in these animals that modified disease incidence. However, this is not likely for the following reasons. First, recipients were randomized into the different experimental groups to control for variation in the incidence of diabetes between different litters. This also would control for the vertical transmission of viruses. Second, the different groups of DCs used in the experiments were all derived from the same pool of donor mice. This would control for the transmission of viruses from donor to recipient. All recipient mice were housed under the same environmental conditions as were colony mice. We did not detect a lower incidence of diabetes in colony mice, or in the experimental control groups (i.e., A/I LN DC group) during the experimental observation period. Finally, we found that the NOD mice that received PLN 
